Your cart is currently empty!

New Howp in the Fecht Agin Opioid Addiction
New Howp in the Fecht Agin Opioid Addiction
The University o Glesga has launched a grundbrakkin research initiative for tae tackle the pressin issue o opioid addiction. Backed by a substantial £5 million grant fae the Wellcome Trust, this project brings thegither an international team o experts determined tae find a wey tae harness the pain-relief benefits o opioids ithoot the peril o addiction.
Leadin the chairge is Professor Andrew Tobin fae the University o Glesga, alangside Dr. Carrie Jones fae Vanderbilt University an Dr. Craig Lindsey fae the Warren Centre for Neuroscience Drug Discovery. Their goal is clear: tae disrupt the brain pathweys that lead tae addiction. They plan tae achieve this by developin new drug-like molecules that specifically target a brain protein kent as the M5-receptor.
Early studies hae shawn promisin results. In tests wi moose models, inhibitin the M5-receptor significantly reduced addiction tae prescribed opioids while still allouin for effective pain relief. The research team is eager tae bigg on these initial findins, aimin tae deepen their unnerstaundin o the M5-receptor’s biology an tae uncover innovative treatment methods that cuid lessen the grip o addiction.
The opioid crisis is a global challenge, wi ower 26 million fowk estimated tae suffer fae opioid yaise (uise) disorder (OUD). Monie fowk faw intae addiction efter usin prescribed opioid pain medications for surgeries or injuries. In the United States alane, ower 2.7 million fowk are reported tae hae OUD. The situation is dire in the UK, whaur ower hauf o adults in treatment for substance abuse are mis-yaisin opioids. In Scotland, opioids are linked tae mair than 80% o the ill-yaise o drugs deaths.
Professor Andrew Tobin expressed his enthusiasm for the fundin, pyntin oot the potential impact this research cuid hae on resolvin the opioid crisis. Dr. Carrie Jones noted the chance tae fulfil a lang-held dream o clinicians: tae manage pain in fowk yaisin opioids wioot the risk o addiction. Charles Maasz, CEO o Glesga Ceety Mission, walcomed the research, emphasisin its importance in addressin addiction an hamelessness in Glesga.
This initiative staunds as a beacon o howp in the fecht agin opioid addiction, aimin tae chynge lives an mak health ootcomes better for coontless individuals.